Abstract
Background
Platelets play an important role in hemostatic and inflammatory responses. To evaluate any potential enhancement of platelet activity in patients with inflammatory bowel disease (IBD), we measured the platelet aggregation responses to various stimuli.
Methods
Twenty-two healthy controls, 24 patients with ulcerative colitis (UC) and 25 patients with Crohn's Disease (CD) were studied. The aggregation responses induced by three agonists (epinephrine, collagen, and ADP) were measured by an 8-channel aggregometer. The platelet-derived microparticles (PDMP) levels were measured by an enzyme-linked immunosorbent assay.
Results
Twenty-one out of the 22 healthy controls did not respond to epinephrine (0.1 µg/ml), collagen (0.2 µg/ml), or ADP (1.0 µM). Eight out of the 12 active UC patients were sensitive to all agonists, and 4 patients showed increased sensitivity to epinephrine/collagen or epinephrine/ADP. Three out of the 12 inactive UC patients were normal, but 9 of these patients showed increased sensitivity, mainly to epinephrine. Ten out of the 12 active CD patients were sensitive to all agonists, and 2 active CD patients were sensitive to epinephrine/collagen or epinephrine/ADP. Eight out of the 13 inactive CD patients were sensitive to two or all agonists. Even after remission, almost all of the UC and CD patients showed some increased sensitivity to the agonists. The platelet number and the plasma PDMP levels were significantly higher in the active IBD patients than in the control group.
Conclusions
Platelet aggregation responses are enhanced in IBD, even in inactive-phase patients. This increased sensitivity of the platelets may play an important role in the pathophysiology of IBD.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
S Danese C de la Motte C Fiocchi (2004) ArticleTitlePlatelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications Am J Gastroenterol 99 938–45 Occurrence Handle10.1111/j.1572-0241.2004.04129.x Occurrence Handle15128364
AS Weyrich GA Zimmerman (2004) ArticleTitlePlatelets: signaling cells in the immune continuum Trends Immunol 25 489–95 Occurrence Handle10.1016/j.it.2004.07.003 Occurrence Handle1:CAS:528:DC%2BD2cXmvFWmu7s%3D Occurrence Handle15324742
I Talstad K Rootwelt E Gjone (1973) ArticleTitleThrombocytosis in ulcerative colitis and Crohn's disease Scand J Gastroenterol 8 135–8 Occurrence Handle1:STN:280:CSyC2MrnsF0%3D Occurrence Handle4697073
JW van Wersch P Houben J Rijken (1990) ArticleTitlePlatelet count, platelet function, coagulation activity and fibrinolysis in the acute phase of inflammatory bowel disease J Clin Chem Clin Biochem 28 513–7 Occurrence Handle1:STN:280:By6D2sbnvFM%3D Occurrence Handle2258713
AN Kapsoritakis MI Koukourakis A Sfiridaki SP Potamianos MG Kosmadaki IE Koutroubakis et al. (2001) ArticleTitleMean platelet volume: a useful marker of inflammatory bowel disease activity Am J Gastroenterol 96 776–81 Occurrence Handle10.1111/j.1572-0241.2001.03621.x Occurrence Handle1:STN:280:DC%2BD3M7ovFOrsA%3D%3D Occurrence Handle11280550
AJ Wakefield AM Sawyerr AP Dhillon RM Pittilo PM Rowles AA Lewis et al. (1989) ArticleTitlePathogenesis of Crohn's disease: multifocal gastrointestinal infarction Lancet 2 1057–62 Occurrence Handle1:STN:280:By%2BD2c3ns1Q%3D Occurrence Handle2572794
R Quera F Shanahan (2004) ArticleTitleThromboembolism—an important manifestation of inflammatory bowel disease Am J Gastroenterol 99 1971–3 Occurrence Handle10.1111/j.1572-0241.2004.40923.x Occurrence Handle15447758
W Miehsler W Reinisch E Valic W Osterode W Tillinger T Feichtenschlager et al. (2004) ArticleTitleIs inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 53 542–8 Occurrence Handle10.1136/gut.2003.025411 Occurrence Handle1:STN:280:DC%2BD2c7lvFWhsw%3D%3D Occurrence Handle15016749
CE Collins MR Cahill AC Newland DS Rampton (1994) ArticleTitlePlatelets circulate in an activated state in inflammatory bowel disease Gastroenterology 106 840–5 Occurrence Handle1:STN:280:ByuC1M3psFM%3D Occurrence Handle8143990
AA Vrij J Rijken JW Van Wersch RW Stockbrugger (2000) ArticleTitlePlatelet factor 4 and beta-thromboglobulin in inflammatory bowel disease and giant cell arteritis Eur J Clin Invest 30 188–94 Occurrence Handle10.1046/j.1365-2362.2000.00616.x Occurrence Handle1:CAS:528:DC%2BD3cXitlSjs70%3D Occurrence Handle10691994
S Danese C de la Motte A Sturm JD Vogal GA West SA Strong et al. (2003) ArticleTitlePlatelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients Gastroenterology 124 1249–64 Occurrence Handle10.1016/S0016-5085(03)00289-0 Occurrence Handle1:CAS:528:DC%2BD3sXktVSktrs%3D Occurrence Handle12730866
S Danese JA Katz S Saibeni A Papa A Gasbarrini M Vecchi et al. (2003) ArticleTitleActivated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients Gut 52 1435–41 Occurrence Handle10.1136/gut.52.10.1435 Occurrence Handle1:CAS:528:DC%2BD3sXotl2lu7c%3D Occurrence Handle12970136
GA Adamus (1985) Platelet aggregation GL Longenecker (Eds) The platelets, physiology and pharmacology Academic New York 1–11
MJ Webberley MT Hart V Melikian (1993) ArticleTitleThromboembolism in inflammatory bowel disease: role of platelets Gut 34 247–51 Occurrence Handle1:STN:280:ByyC283lsVQ%3D Occurrence Handle8432482
D Rachmilewitz (1989) ArticleTitleCoated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial BMJ 298 82–86 Occurrence Handle1:STN:280:BiaC2M%2FntFA%3D Occurrence Handle2563951
WR Best JM Becktel JW Singleton F Kern SuffixJr (1976) ArticleTitleDevelopment of a Crohn's disease activity index. National Cooperative Crohn's Disease Study Gastroenterology 70 439–44 Occurrence Handle1:STN:280:CSmC3MflsFA%3D Occurrence Handle1248701
K Osumi Y Ozeki S Saito Y Nagamura H Ito Y Kimura et al. (2001) ArticleTitleDevelopment and assessment of enzyme immunoassay for platelet-derived microparticles Thromb Haemost 85 326–30 Occurrence Handle1:CAS:528:DC%2BD3MXhvVKrsL0%3D Occurrence Handle11246556
A Andoh T Tsujikawa K Hata Y Araki K Kitoh M Sasaki et al. (2005) ArticleTitleElevated circulating platelet-derived microparticles in patients with active inflammatory bowel disease Am J Gastroenterol 100 2042–8 Occurrence Handle10.1111/j.1572-0241.2005.50381.x Occurrence Handle16128950
MA Packham JF Mustard (1977) ArticleTitleClinical pharmacology of platelets Blood 50 555–573 Occurrence Handle1:CAS:528:DyaE2sXlslOhtb4%3D Occurrence Handle332253
JP Fagerstam PA Whiss M Strom RG Andersson (2000) ArticleTitleExpression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease Inflamm Res 49 466–72 Occurrence Handle1:CAS:528:DC%2BD3cXntlOktLg%3D Occurrence Handle11071121
HS Yun-Choi KM Park MK Pyo (2000) ArticleTitleEpinephrine induced platelet aggregation in rat platelet-rich plasma Thromb Res 100 511–8 Occurrence Handle10.1016/S0049-3848(00)00353-4 Occurrence Handle1:CAS:528:DC%2BD3MXitlensw%3D%3D Occurrence Handle11152931
RH Straub H Herfarth W Falk T Andus J Scholmerich (2002) ArticleTitleUncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease? J Neuroimmunol 126 116–25 Occurrence Handle10.1016/S0165-5728(02)00047-4 Occurrence Handle1:CAS:528:DC%2BD38XjvVaqt7s%3D Occurrence Handle12020963
A Nakajima W Sendo M Tsutsumino Y Koseki N Ichikawa H Akama et al. (1998) ArticleTitleAcute sympathetic hyperfunction in overlapping syndromes of systemic lupus erythematosus and polymyositis J Rheumatol 25 1638–41 Occurrence Handle1:STN:280:DyaK1cznsF2gsw%3D%3D Occurrence Handle9712113
F Perry PH Heller J Kamiya JD Levine (1989) ArticleTitleAltered autonomic function in patients with arthritis or with chronic myofascial pain Pain 39 77–84 Occurrence Handle10.1016/0304-3959(89)90177-2 Occurrence Handle1:STN:280:By%2BD2crlvVI%3D Occurrence Handle2812855
MJ Morris AE Russell V Kapoor MD Cain JM Elliott MJ West et al. (1986) ArticleTitleIncreases in plasma neuropeptide Y concentrations during sympathetic activation in man J Auton Nerv Syst 17 143–9 Occurrence Handle10.1016/0165-1838(86)90089-5 Occurrence Handle1:CAS:528:DyaL28XmtF2ns7Y%3D Occurrence Handle3782722
MJ VanWijk E VanBavel A Sturk R Nieuwland (2003) ArticleTitleMicroparticles in cardiovascular diseases Cardiovasc Res 59 277–87 Occurrence Handle10.1016/S0008-6363(03)00367-5 Occurrence Handle1:CAS:528:DC%2BD3sXlvFyhs7k%3D Occurrence Handle12909311
CH Gemmell MV Sefton EL Yeo (1993) ArticleTitlePlatelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect J Biol Chem 268 14586–9 Occurrence Handle1:CAS:528:DyaK3sXlsFKqsr4%3D Occurrence Handle8325838
S Nomura (2001) ArticleTitleFunction and clinical significance of platelet-derived microparticles Int J Hematol 74 397–404 Occurrence Handle1:STN:280:DC%2BD38%2FmslCgtA%3D%3D Occurrence Handle11794694
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andoh, A., Yoshida, T., Yagi, Y. et al. Increased aggregation response of platelets in patients with inflammatory bowel disease. J Gastroenterol 41, 47–54 (2006). https://doi.org/10.1007/s00535-005-1721-x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00535-005-1721-x